MediPharm Labs Provides Update on VIVO Integration and Board Appointee
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs”, “MediPharm” or the “Company”) a pharmaceutical company specialized in precision…
- MediPharm Labs begins restructuring immediately following completion of its acquisition of VIVO and reiterates confidence in $7 to 9M of projected annualized synergies. (1)(2)(3)(4)